NCJ Number
253022
Date Published
August 2018
Length
8 pages
Annotation
Information and data are presented for the New York Prescription Drug Monitoring Program (PDMP), which is named the Internet System for Tracking Over-Prescribing (I-STOP).
Abstract
I-STOP is administered by the New York State Department of Health/Bureau of Narcotic Enforcement. The PDMP email address is provided, along with the website addresses for the home page, enrollment, queries, and data upload. Contact information is provided for the PDMP Director. Statistics for 2017 cover the state population (19,862,512), DEA registered drug prescribers (117,337), and DEA registered drug dispensers (5,431). PDMP available reports are listed. Funding for the PDMP in 2018 is reported as "Special Funds." Staff numbers for 2018 are reported for the following job categories: operational (3), technical (2), analytical (1), and "other" (0). Key PDMP dates pertain to enabling legislation (1972), becoming operational (April 1973), initial user access (February 2010), and electronic reporting (1999). Source information is provided for statutes and rules related to PDMP policies and procedures. Reporting frequency for monitored drugs is every 24 hours. Monitored drugs are controlled substances in schedules II, III, IV, and V. as well as marijuana data, ARCOS data, and drug manufacturers or distributors data. The PDMP has the authority to monitor other substances. Miscellaneous PDMP capabilities and policies are listed. Prescribers, but not dispensers, are required to use the PDMP. Law enforcement agencies must have a subpoena to access PDMP data. A data retention policy requires that patient information be regularly purged while retaining de-identified data. Training in using the PDMP is available for prescribers, but is not required. Technological capabilities of the PDMP are reported for ASAP versions accepted; data transmission methods allowed; required data transmitters; data collection, storage, generation, and access; interstate data sharing; data integration; and patient matching. Reports authorized for production by requestor type are indicated.